Sectors
BIOA
BioAge Labs, Inc.
9.50
5 x 9.31
2 x 11.80
bid
ask
-
0.15
1.55%
4 @ 07:57 PM
9.40 -0.10 (1.05%)
| Ytd | -28.19% | |
| 1y | 92.70% |
9.20
day range
9.62
4.55
52 week range
25.95
| Open | 9.61 | Prev Close | 9.65 | Low | 9.20 | High | 9.62 | Mkt Cap | 436.02M |
| Vol | 1.03M | Avg Vol | 842.40K | EPS | -2.39 | P/E | N/A | Forward P/E | -12.08 |
| Beta | 0.93 | Short Ratio | 4.63 | Inst. Own | 85.48% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 17.72 | 200-d Avg | 16.89 | 1yr Est | 49.50 |
| Income Statement | |||
| Total Revenue | 2.45M | ||
| Revenues (USD) | 2.45M | ||
| Gross Profit | 2.45M | ||
| Operating Expenses | 31.78M | ||
| Research and Development Expense | 24.37M | ||
| Selling, General and Administrative Expense | 7.42M | ||
| Operating Income | -29.33M | ||
| Interest Expense | 1000 | ||
| Net Income | -26.10M | ||
| Net Income Common Stock | -26.10M | ||
| Net Income Common Stock (USD) | -26.10M | ||
| Consolidated Income | -26.10M | ||
| Earnings per Basic Share | -0.58 | ||
| Earnings per Basic Share (USD) | -0.58 | ||
| Earnings per Diluted Share | -0.58 | ||
| Earning Before Interest & Taxes (EBIT) | -26.10M | ||
| Earning Before Interest & Taxes (USD) | -26.10M | ||
| Weighted Average Shares | 44.84M | ||
| Weighted Average Shares Diluted | 44.84M | ||
| Balance Sheet | |||
| Cash and Equivalents | 73.96M | ||
| Cash and Equivalents (USD) | 73.96M | ||
| Investments | 307.40M | ||
| Investments Current | 244.78M | ||
| Investments Non-Current | 62.62M | ||
| Trade and Non-Trade Receivables | 625.00K | ||
| Current Assets | 330.31M | ||
| Property, Plant & Equipment Net | 3.79M | ||
| Total Assets | 396.93M | ||
| Debt Current | 714.00K | ||
| Total Debt | 2.84M | ||
| Current Liabilities | 19.22M | ||
| Debt Non-Current | 2.12M | ||
| Total Liabilities | 22.02M | ||
| Accumulated Retained Earnings (Deficit) | -381.77M | ||
| Accumulated Other Comprehensive Income | -478.00K | ||
| Shareholders Equity | 374.91M | ||
| Shareholders Equity (USD) | 374.91M | ||
| Assets Non-Current | 66.62M | ||
| Total Debt (USD) | 2.84M | ||
| Deferred Revenue | 4.36M | ||
| Liabilities Non-Current | 2.80M | ||
| Trade and Non-Trade Payables | 5.65M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 133.00K | ||
| Net Cash Flow from Financing | 15.97M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -167.81M | ||
| Capital Expenditure | -328.00K | ||
| Issuance (Purchase) of Equity Shares | 17.12M | ||
| Issuance (Repayment) of Debt Securities | -1.16M | ||
| Net Cash Flow from Investing | -164.51M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -164.19M | ||
| Net Cash Flow from Operations | -19.26M | ||
| Effect of Exchange Rate Changes on Cash | -5.00K | ||
| Share Based Compensation | 4.27M | ||